Allan Lohse
Papers
1
Total Citations
24
H-Index
1
About
Allan Lohse is a leading clinical neuroscientist whose research focuses on the pathophysiology and treatment of movement disorders, particularly Parkinson’s disease. His major contributions lie in understanding the neural mechanisms underlying levodopa-induced dyskinesia—a debilitating complication of long-term dopamine therapy. In his landmark 2020 randomized cross-over trial, Lohse demonstrated that low-frequency transcranial stimulation of the pre-supplementary motor area can significantly alleviate these involuntary movements, offering a non-invasive therapeutic avenue for patients. This work, which has garnered 24 citations, builds on his earlier pharmacodynamic functional MRI studies revealing that levodopa triggers excessive activation in this cortical region. Lohse’s research bridges cutting-edge neuroimaging with translational neuromodulation, directly addressing a critical unmet need in Parkinson’s care. His findings have been widely recognized for their clinical relevance, providing a foundation for future personalized stimulation protocols. Through rigorous trial design and mechanistic insight, Lohse continues to shape how we treat the motor complications of Parkinson’s disease, improving quality of life for patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1